2021
DOI: 10.3233/shti210591
|View full text |Cite
|
Sign up to set email alerts
|

Machine Learning Based Metagenomic Prediction of Inflammatory Bowel Disease

Abstract: In this study, we investigate faecal microbiota composition, in an attempt to evaluate performance of classification algorithms in identifying Inflammatory Bowel Disease (IBD) and its two types: Crohn’s disease (CD) and ulcerative colitis (UC). From many investigated algorithms, a random forest (RF) classifier was selected for detailed evaluation in three-class (CD versus UC versus nonIBD) classification task and two binary (nonIBD versus IBD and CD versus UC) classification tasks. We dealt with class imbalanc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…Several recent studies have highlighted the advantages of implementing the ML pipeline on SM data to understand microbial taxa, identify signatures for disease identification and diagnose complex medical conditions, particularly for gut microbiome-related diseases. These studies demonstrate the following key benefits: (I) Improved Classification Accuracy to taxa associated with IBD: Mihajlović et al ( 2021 ) employed a random forest (RF) model to classify Inflammatory Bowel Disease (IBD), achieving an average F1 score of 91%. This underscores the robust connection between IBD and the gut microbiome, showcasing how ML can enhance diagnostic accuracy in complex diseases.…”
Section: Machine Learning For Microbiome Data Analysismentioning
confidence: 99%
“…Several recent studies have highlighted the advantages of implementing the ML pipeline on SM data to understand microbial taxa, identify signatures for disease identification and diagnose complex medical conditions, particularly for gut microbiome-related diseases. These studies demonstrate the following key benefits: (I) Improved Classification Accuracy to taxa associated with IBD: Mihajlović et al ( 2021 ) employed a random forest (RF) model to classify Inflammatory Bowel Disease (IBD), achieving an average F1 score of 91%. This underscores the robust connection between IBD and the gut microbiome, showcasing how ML can enhance diagnostic accuracy in complex diseases.…”
Section: Machine Learning For Microbiome Data Analysismentioning
confidence: 99%
“…The employed learning techniques are KNN and SVM where SVM proves to be superior with a 92% accuracy score. The inflammatory bowel disease prediction using machine learning techniques is proposed in the study [28]. The metagenomic dataset on inflammatory bowel disease multi-omics is utilized for machine learning model building and experimental research evaluations.…”
Section: Related Workmentioning
confidence: 99%
“…Automated image recognition using deep learning methods also has been applied in the endoscopic images and pathological images recognition of IBD ( 21 , 26 28 ). Moreover, in search of new well-performing markers at the gene and microbiome level, the ML methods showed the greatest contribution in variables screening ( 29 , 30 ). Based on the development of these techniques, introducing ML into the area of UC evaluation can provide a promising approach for researchers.…”
Section: Introductionmentioning
confidence: 99%